| Literature DB >> 17557120 |
Masahisa Jinushi1, Yukoh Nakazaki, Michael Dougan, Daniel R Carrasco, Martin Mihm, Glenn Dranoff.
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances protection against tumors and infections, but GM-CSF-deficient mice develop inflammatory disease. Here we show that GM-CSF is required for the expression of milk fat globule EGF 8 (MFG-E8) in antigen-presenting cells, and that MFG-E8-mediated uptake of apoptotic cells is a key determinant of GM-CSF-triggered tolerance and immunity. Upon exposure to apoptotic cells, GM-CSF-deficient antigen-presenting cells (APCs) produce an altered cytokine profile that results in decreased Tregs and increased Th1 cells, whereas concurrent ablation of IFN-gamma promotes Th17 cells. In wild-type mice, MFG-E8 attenuates the vaccination activity of GM-CSF-secreting tumor cells through Treg induction, whereas a dominant-negative MFG-E8 mutant potentiates GM-CSF-stimulated tumor destruction through Treg inhibition. These findings clarify the immunoregulatory effects of apoptotic cells and suggest new therapeutic strategies to modulate CD4(+) T cell subsets in cancer and autoimmunity.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17557120 PMCID: PMC1884688 DOI: 10.1172/JCI30966
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808